Dr. Crown is a 2021 Seattle Met Top Doctor Award winner. She has clinical expertise in benign and malignant breast diseases and her training in oncoplastic surgery allows her to offer innovative surgical approaches that maximize oncologic and aesthetic outcomes. She enjoys getting to know her patients and is passionate about creating individualized multidisciplinary treatment plans that integrate their values and preferences with evidence-based practice and emerging research. Dr. Crown has published over 40 peer-reviewed papers and book chapters. Her current research focuses on oncoplastic surgery, health care access and disparities, pregnancy-associated breast cancer, oncofertility, and surgical decision-making and recurrence after neoadjuvant systemic therapy.
Clinical Trials: Site Primary Investigator: Alliance A221702: ARM: Axillary Reverse Mapping - A Prospective Trial to Study Rates of Lymphedema and Regional Recurrence After Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection With and Without Axillary Reverse Mapping.
Site Primary Investigator: TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer.
University of Pennsylvania
Virginia Mason Medical Center
Memorial Sloan Kettering Cancer Center
Cancer Care Standards Development Committee - American College of Surgeons
Society of Surgical Oncology
Health Equity Advisory Group - American Society of Breast Surgeons
Association of Women Surgeons
Locoregional Working Group and Breast Cancer Committee - Alliance for Clinical Trials
First Hill Surgery Center Operations Council
Research Steering Committee - Swedish Cancer Institute
Fellows Working Group - American Society of Breast Surgeons
Aesthetic Flat Closure Working Group
Clinical Competency Committee - Swedish Medical Center General Surgery Program
American Board of Surgery, Surgery
Kauffman AS, Gottsch ML, Roa J, Byquist AC, Crown A, Clifton DK, Hoffman GE, Steiner RA, Tena-Sempere M. Sexual Differentiation of Kiss1 Gene Expression in the Brain of the Rat. Endocrinology. 2007;148(4):1774-83.
Crown A, Clifton DK, Steiner RA. Neuropeptide Signaling in the Integration of Metabolism and Reproduction. Neuroendocrinology. 2007;86(3):175-182.
Crown A, Wechter DG, Grumley JW. Oncoplastic Breast Conserving Surgery Reduces Mastectomy and Postoperative Re-excision Rates. Annals of Surgical Oncology. 2015; 22(10):3363-8.
Crown A, Biehl TR, Rocha FG. Limited Resections for Gastrointestinal Stromal Tumors. American Journal of Surgery. 2016;211(5):867-70.
Bertens KA, Crown A, Clanton J, Alemi F, Alseidi AA, Biehl T, Helton WS, Rocha FG. What is a better predictor of clinically relevant postoperative pancreatic fistula (CR-POPF) following pancreaticoduodenectomy (PD): postoperative day one drain amylase (POD1DA) or the fistula risk score (FRS)? HPB (Oxford). 2017;19(1):75-81.
Burke CR, Crown A, Chan T, McMullan DM. Extracorporeal life support is safe in trauma patients. Injury. 2017;48(1):121-126.
Crown A, Grumley JW. Association of Intraoperative Radiotherapy in the Treatment of Early-Stage Breast Cancer With Minor Surgical Site Complications in Oncoplastic Breast-Conserving Surgery. JAMA Surgery. 2017;152(12):1190-1192.
Crown A, Handy N, Rocha FG, Grumley JW. Oncoplastic reduction mammaplasty, an effective and safe method of breast conservation. American Journal of Surgery. 2018; 215(5):910-915.
Crown A, Scovel LG, Deal SB, Kramer DK, Wechter DG, Grumley JW. Clinical and Radiological Follow Up Rather Than Excisional Biopsy Is Reasonable After Complete Papilloma Excision at the Time of Core Needle Biopsy. The Breast Journal. 2018; 24(5):841-842.
Crown A, Scovel LG, Scott EJ, Wechter DG, and Grumley JW. Oncoplastic Breast Conserving Surgery Is Associated with Lower Rate of Surgical Site Complications Compared to Standard Breast Conserving Surgery. American Journal of Surgery. 2019;217(1):138-141.
Crown A, Laskin R, Rocha FG, Grumley JW. Extreme Oncoplasty: Expanding Indications for Breast Conservation. American Journal of Surgery. 2019;217(5):851-856.
Crown A, Kennecke H, Kozarek R, Lopez-Aguiar AG, Dillhoff M, Poultsides GA, Makris EA, Idrees K, Smith PM, Nathan H, Beems M, Weber SM, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG. Gastric carcinoids: Does type of surgery or tumor affect survival? American Journal of Surgery. 2019;217(5):937-942.
Crown A, Grumley JW. Biopsy-proven Lymph Nodes Predict Axillary Nodal Response Following Neoadjuvant Chemotherapy in Node-positive Breast Cancer. The Breast Journal. 2019;25(5):1023-1024.
Crown A, Rocha FG, Grumley JW. Oncoplastic Central Partial Mastectomy and Neoareolar Reduction Mammoplasty with Immediate Nipple Reconstruction: An Initial Report of a Novel Option for Breast Conservation in Patients with Subareolar Tumors. Annals of Surgical Oncology. 2019;26(13):4284-4293.
Crown A, Rocha FG, Grumley JW. Intraoperative Radiation Therapy: Lobular Histology Is Not Associated with Increased Risk of Requiring Additional Therapy. American Journal of Surgery. 2019;217(5):937-942.
Zaidi M, Lopez-Aguiar AG, Dillhoff ME, Beal EW, Poultsides GA, Makris EA, Rocha FG, Crown A, Idrees K, Smith PM, Nathan H, Beems M, Abbott DE, Barrett JR, Fields RC, Davidson JT, Cardona K, Maithel SK. Defining the number of lymph nodes needed to accurately stage small bowel neuroendocrine tumors: An 8-institution study from the US neuroendocrine tumor study group. JAMA Surgery. 2019;154(2):134-140.
Kimbrough C, Beal EW, Dillhoff ME, Schmidt CR, Pawlik TM, Lopez-Aguiar AG, Poultsides GA, Makris EA, Rocha FG, Crown A, Abbott DE, Fisher AV, Fields RC, Krasnick BA, Idrees K, Marincola Smith, P; Cho CS, Beems M, Maithel SK, Cloyd JM. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing surgical resection. Surgery. 2019;165(3):657-663.
Armstrong EA, Beal EW, Lopez-Aguiar AG, Poultsides G, Cannon JG, Rocha F, Crown A, Barrett J, Ronnkleiv-Kelly S, Fields RC, Krasnick BA, Idrees K, Smith PM, Nathan H, Beems MV, Maithel SK, Schmidt CR, Pawlik TM, Dillhoff M. Evaluating the ACS-NSQUIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group. The American Surgeon. 2019;85(12):1334-1340.
Crown A, Simianu VV, Kennecke H, Lopez-Aguiar AG, Dilhoff M, Beal EW, Poultsides GA, Makris E, Idrees K, Marincola Smith P, Nathan H, Beems M, Abbott D, Fisher AV, Fields RC, Davidson J, Maithel SK, Rocha FG. Appendiceal neuroendocrine tumors: Does colon resection improve outcomes? Journal of Gastrointestinal Surgery. 2020;24(9):2121-2126.
Marincola Smith P, Baechle J, Solorzano CC, Tan M, Lopez-Aguiar AG, Dillhoff M, Beal E, Poulsides G, Cannon JGD, Rocha FG, Crown A, Cho C, Beems E, Winslow ER, Rendell VR, Krasnick BA, Fields RC, Maithel SK, Bailey CE, Idrees K. Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study Group. HPB. 2020;22(7):1042-1050.
Crown A, Rocha FG, Raghu P, Lin B, Funk G, Alseidi AA, Hubka M, Rosales J, Lee M, Kennecke H. Impact of Gallium-68 Dotatate PET/CT imaging on the oncologic management of patients with neuroendocrine tumors. Journal of Surgical Oncology. 2020;121(3):480-485.
Marincola Smith P, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Makris EA, Rocha FG, Crown A, Cho CS, Beems M, Winslow ER, Rendell V, Krasnick BA, Fields RC, Maithel SK, Idrees K. Impact of insurance status on survival in neuroendocrine tumors: A multi-institutional Study from the U.S. Neuroendocrine Study Group. 2020. Annals of Surgical Oncology. 2020; 27(9):3147-3153.
Barrett JR, Rendell V, Pokrzywa C, Lopez-Aguiar AG, Cannon J, Poultsides GA, Rocha FG, Crown A, Beal E, Pawlick T, Fields RC, Panni R, Marincola Smith P, Idrees K, Cho CS, Beems M, Maithel SK, Weber S, Abbott D. Adjuvant Therapy Following Resection of Gastroenteropancreatic Neuroendocrine Tumors Provides No Recurrence or Survival Benefit. Journal of Surgical Oncology. 2020; 121(7):1067-1073.
Crown A, Laskin RG, Weed CN, Rocha FG, Grumley JW. Evaluating need for additional imaging and biopsy after oncoplastic breast conserving surgery. Annals of Surgical Oncology. 2020. Epub ahead of print.
Crown A, Muhsen S, Zabor EC, Sevilimedu V, Kelvin J, Goldfarb S, Gemignani ML. Does Use of Neoadjuvant Chemotherapy Affect Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer? Annals of Surgical Oncology. 2020. Epub ahead of print.
Baechle JJ, Marincola Smith P, Tan M, Solorzano C, Lopez-Aguiar AG, Dillhoff M, Beal EW, Poultsides GA, Cannon J, Rocha FG, Crown A, Cho CS, Beems M, Winslow ER, Rendell V, Maithel SK, Bailey C, Idrees K. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study from the United States Neuroendocrine Study Group. Annals of Surgical Oncology. 2020. Epub ahead of print.
Crown A, Berry C, Khabele D, Fayanju OM, Cobb A, Backhus L, Smith R, Sweeting F, Hasson R, Johnson-Mann C, Oseni T, Newman EA, Turner P, Karpeh M, Pugh C, Hayes-Jordan A, Henry-Tillman R, Joseph, KA. The Role in the Career Experiences of Black/African-American (AA) Academic Surgeons: A Survey of the Society of Black Academic Surgeons and a Call to Action. Annals of Surgery. 2020. Epub ahead of print.
Crown A, Gonen M, Le T, Morrow M. Does Failure to Achieve Pathologic Complete Response with Neoadjuvant Chemotherapy Identify Node Negative Patients Who Would Benefit from Postmastectomy Radiation or Nodal Irradiation? Annals of Surgical Oncology. 2020. Epub ahead of print.
Crown A, Weed C, Laskin R, Rocha FG, Grumley JG. Oncoplastic Surgery: Can We Reduce Rates of Mastectomy and Chemotherapy? Annals of Surgical Oncology. 2020. Epub ahead of print.
Crown A, Choi J, Cole-Price A, Horowitz E, Joseph, KA. Optimizing Care of Breast Cancer Patients from Low Resource Countries Who Immigrate to New York City: A Case Series from a Large Public Hospital. The Breast Journal. 2020. Epub ahead of print.
Crown A, Carlson E, Rocha FG, Grumley JG. Oncoplastic breast conserving therapy and intraoperative radiotherapy for management of carcinoma in situ of the breast: a single center experience. The Breast Journal. In press.
Escobar N, Crown A, Pocock B, Joseph KA. The Devastating Impact of the COVID-19 Pandemic on Breast Cancer Care Among Medically Underserved Populations at Two New York City Public Hospitals. Annals of Surgery Open. In press.
Dr. Crown enjoys traveling and spending time with her family and pets. A classically trained pianist and singer, she loves opera and ballet. She also enjoys taking barre and spin classes and reading with her book club.
At Swedish, we're dedicated to providing you quality, personalized health care. We are constantly striving to optimize your experience.
As part of ensuring you have a positive experience with Swedish, our online provider directory includes ratings and patient comments for select providers. More about our survey.
543 Ratings | 5 Comments
Angelena Crown, M.D.
Dr Crown is awesome. I feel that I am in good hands.
Angelena Crown, M.D.
Everyone took care of me. Everyone felt like they did their part. Everyone was kind and easy to get a hold of.
Angelena Crown, M.D.
Dr. Crown is great
Angelena Crown, M.D.
These are unprecedented and challenging times for everyone-- particularly medical care providers. I am grateful to Dr. Crown and her staff for making me feel like my concerns / potential problems havn't been overlooked or pushed aside.
Angelena Crown, M.D.
Dr. Crown provided excellent care and has a great bed side manner as well. I would highly recommend her